Clinical Practice & Implementation of Image-Guided Stereotactic Body Radiotherapy
Würzburg • Germany
2 - 6 September 2012
Early rate deadline: 4 June 2012
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
Course Directors
Matthias Guckenberger, Radiation Oncologist, University Hospital Würzburg, Würzburg, Germany (DE)
Dirk Verellen, Physicist, UZ Brussel (VUB), Brussels (BE)
Teachers
Marianne Aznar, Physicist, Rigshospitalet, Copenhagen, Denmark
Karin Diekmann, Radiation Oncologist, Medical University of Vienna, Vienna, Austria
Mischa S. Hoogeman, Physicist, Erasmus Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands
Morten Hoyer, Radiation Oncologist, Aarhus University Hospital, Aarhus, Denmark
Coen Hurkmans, Physicist, Catharina Hospital, Eindhoven, The Netherlands
Eric Lartigau, Radiation Oncologist, Centre Oscar-Lambret et Université Lille-ll, Lille, France
Suresh Senan, Radiation Oncologist, VU University Medical Center, Amsterdam, The Netherlands
Alejandra Méndez Romero, Radiation Oncologist, Erasmus Medical Center-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands
Local organiser
Matthias Guckenberger, Radiation Oncologist, University Hospital Würzburg, Würzburg, Germany (DE)
Course aims
- To understand the radiobiological consequences of hypo-fractionated, inhomogeneous dose distributions
- Cranial radiosurgery: to discuss the practice of frame-less image-guided versus frame-based stereotactic cranial radiosurgery
- To identify potential sources of uncertainties in the work-flow of SBRT: imaging, target delineation, treatment planning, treatment delivery and treatment evaluation
- To offer an overview of available treatment planning and delivery technologies and how to integrate these in clinical practice of SBRT
- To compare available technologies and help define applicability for particular use.
- To give an evidence-based review on potential indications for SBRT: early stage NSCLC, primary and secondary liver metastases, prostate cancer, vertebral metastases, oligometastases, re-irradiation
- To give an overview of normal-tissue toxicity, tolerability and radiological changes in SBRT
- To learn how to establish and implement a clinical program for SBRT
Target group
The course is aimed at all professionals in the field of radiation oncology, who are involved in the clinical practice of SBRT and cranial SRS at any point in the treatment chain: radiation oncologists, physicists and radiation technologists with a dedicated focus on SBRT and SRS. The course targets both individuals, who are currently at the planning stage of establishing a clinical stereotactic program as well as individuals, who already have a running stereotactic practice. A special focus will be the importance of integrating all professionals into a team.
Educational programme
This 5-day ESTRO teaching course shall support establishing and further developing a clinical stereotactic program. The following items will be covered with special focus on special requirements in SBRT:
-
Radiobiology of hypo-fractionated, inhomogeneous dose distributions for normal tissue and cancer cells
-
Uncertainties in clinical practice of SBRT and SRS
-
Technological means for compensation of these uncertainties at all stages of radiotherapy treatment
-
Evidence-based clinical practice of SBRT and potential indications for SBRT
-
Requirements for building and further development of a clinical stereotactic program
On Sunday a site visit is planned at the University Hospital Würzburg: demonstrations of different steps of SBRT will be given. Because no patients are treated on Sunday, practical hands-on will be emphasized. The teaching lectures on Monday will review and discuss the technology and physical practice of SBRT and SRS; on Tuesday, various clinical aspects will be discussed and SBRT for early stage NSCLC be reviewed in detail. In all teaching lectures, we will focus on the multi-disciplinary character of SBRT. Interaction and discussion between the professional groups is highly encouraged. Workshops will be organized on Wednesday, which will focus on different tumors sites: a practical approach to these indications will be demonstrated by case presentations and discussions. The last day will focus on the establishment of a clinical stereotactic program and end with a panel discussion.